Q2/2019: Merck KGaA, Darmstadt, Germany, Sees Profit Jump in Q2

EBITDA pre up sharply, organically driven by Life Science and Healthcare.


  • Net sales growth (+6.9 %) thanks to organic performance
  • EBITDA pre up sharply (+23.8%), organically driven by Life Science and Healthcare
  • Business in Asia continues to drive organic sales growth of the Group
  • Merck KGaA, Darmstadt, Germany, confirms forecast for sales and earnings performance
852 852 Pull Quote Oschmann Stefan 2018 852 852 Pull Quote Oschmann Stefan 2018

We achieved organic sales growth in all regions. The jump in earnings was due to the very good business performance of Life Science as well as the milestone payments in Healthcare. These payments are evidence of our successes in developing innovative medicines.

Stefan Oschmann

Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Sees Profit Jump in Q2

    Merck KGaA, Darmstadt, Germany generated strong net sales growth in the second quarter of 2019, primarily on an organic basis.


Friederike Segeberg

Financial Communications

+49 6151 72-6328

+49 6151 72-3138

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price


You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Internet Explorer is not supported

You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement